REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $672,936 | -16.5% | 6,600 | -25.6% | 0.00% | 0.0% |
Q1 2023 | $806,279 | +64.3% | 8,868 | -31.4% | 0.00% | 0.0% |
Q4 2022 | $490,831 | +64.2% | 12,920 | +8.2% | 0.00% | – |
Q3 2022 | $299,000 | -17.6% | 11,936 | 0.0% | 0.00% | – |
Q2 2022 | $363,000 | -17.7% | 11,936 | -11.3% | 0.00% | – |
Q1 2022 | $441,000 | -52.7% | 13,450 | -62.0% | 0.00% | -100.0% |
Q4 2021 | $932,000 | -65.1% | 35,360 | +33.3% | 0.00% | -66.7% |
Q3 2021 | $2,668,000 | -20.5% | 26,518 | -0.9% | 0.00% | 0.0% |
Q2 2021 | $3,354,000 | +13.7% | 26,765 | -9.5% | 0.00% | 0.0% |
Q1 2021 | $2,950,000 | -11.1% | 29,588 | +10.2% | 0.00% | -25.0% |
Q4 2020 | $3,319,000 | +62.2% | 26,848 | +27.9% | 0.00% | +33.3% |
Q3 2020 | $2,046,000 | -34.4% | 20,997 | +5.0% | 0.00% | -25.0% |
Q2 2020 | $3,120,000 | +2.5% | 19,997 | -5.2% | 0.00% | -20.0% |
Q1 2020 | $3,045,000 | -55.0% | 21,097 | -36.3% | 0.01% | -50.0% |
Q4 2019 | $6,766,000 | +207.0% | 33,097 | +20.6% | 0.01% | +233.3% |
Q3 2019 | $2,204,000 | +18.4% | 27,453 | +39.1% | 0.00% | 0.0% |
Q2 2019 | $1,862,000 | +37.7% | 19,737 | +24.8% | 0.00% | +50.0% |
Q1 2019 | $1,352,000 | +54.3% | 15,813 | +1.3% | 0.00% | 0.0% |
Q4 2018 | $876,000 | -30.0% | 15,613 | +2.0% | 0.00% | 0.0% |
Q3 2018 | $1,252,000 | – | 15,313 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |